Qing-zhou Kong
No. 107, Wenhuaxi Road
Jinan, China
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Optimizing Helicobacter pylori therapy through gastroenterologist education: A prospective interventional study.
Journal: World journal of gastroenterology
Published: October 29, 2025
Seven-Day Versus 14-Day Tegoprazan and Tetracycline-Containing Quadruple Therapy for First-Line Eradication of Helicobacter pylori Infection: A Randomized, Open-Label, Noninferiority Trial.
Journal: Helicobacter
Published: February 18, 2025
Evaluating large language models as patient education tools for inflammatory bowel disease: A comparative study.
Journal: World journal of gastroenterology
Published: October 08, 2024
Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days.
Journal: Digestive diseases and sciences
Published: December 05, 2023
Low-dose or high-dose amoxicillin in vonoprazan-based dual therapy for Helicobacter pylori eradication? A systematic review and meta-analysis.
Journal: Helicobacter
Published: November 30, 2023
Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study.
Journal: Journal of gastroenterology and hepatology
Published: June 09, 2023
Inadequate gastric preparation and its associated factors for magnetically controlled capsule endoscopy.
Journal: Frontiers in pharmacology
Published: March 12, 2023
The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis.
Journal: Clinical and experimental medicine
Published: June 05, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026